HU9600376D0 - A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient - Google Patents

A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Info

Publication number
HU9600376D0
HU9600376D0 HU9600376A HU9600376A HU9600376D0 HU 9600376 D0 HU9600376 D0 HU 9600376D0 HU 9600376 A HU9600376 A HU 9600376A HU 9600376 A HU9600376 A HU 9600376A HU 9600376 D0 HU9600376 D0 HU 9600376D0
Authority
HU
Hungary
Prior art keywords
progesterone
excipient
polyethylene glycol
oral administration
novel pharmaceutical
Prior art date
Application number
HU9600376A
Other languages
Hungarian (hu)
Other versions
HUT74167A (en
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HU9600376D0 publication Critical patent/HU9600376D0/en
Publication of HUT74167A publication Critical patent/HUT74167A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HU9600376A 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol HUT74167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (en) 1993-08-20 1993-08-20 PHARMACEUTICAL FORMULA CONTAINING A HORMON

Publications (2)

Publication Number Publication Date
HU9600376D0 true HU9600376D0 (en) 1996-04-29
HUT74167A HUT74167A (en) 1996-11-28

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600376A HUT74167A (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol

Country Status (17)

Country Link
EP (1) EP0789560A1 (en)
JP (1) JPH09501682A (en)
KR (1) KR960703570A (en)
CN (1) CN1132478A (en)
AU (1) AU7530594A (en)
BR (1) BR9407306A (en)
CA (1) CA2169840A1 (en)
CZ (1) CZ42596A3 (en)
DK (1) DK95093D0 (en)
FI (1) FI960749A (en)
HU (1) HUT74167A (en)
LT (1) LT4043B (en)
NO (1) NO960653D0 (en)
NZ (1) NZ271617A (en)
PL (1) PL313113A1 (en)
SK (1) SK19396A3 (en)
WO (1) WO1995005807A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (en) * 1997-12-19 2001-03-09 Besins Iscovesco Lab PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
FR2775599B1 (en) * 1998-03-09 2001-08-17 Besins Iscovesco Lab PHARMACEUTICAL COMPOSITION BASED ON SYNTHESIS NATURAL PROGESTERONE AND OESTRADIOL AND PROCESS FOR PREPARING THE SAME
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
JP4354667B2 (en) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト Medicinal combination of ethinylestradiol and drospirenone for use as a contraceptive
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (en) * 2000-12-18 2002-06-19 Licentia Oy Entero-coated pharmaceutical compositions and their preparation
AU2002242339A1 (en) * 2002-03-14 2003-09-29 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
AU2006287925B2 (en) 2005-04-28 2012-03-01 Wyeth Compositions containing micronized tanaproget
EP2055306A1 (en) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Application of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/media for lactose-free oral contraception
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (en) 2011-11-23 2021-09-02 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (en) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. NATURAL COMBINED HORMONE SUBSTITUTION COMPOSITIONS AND THERAPIES
BR112017027688A2 (en) 2015-06-22 2018-09-04 Lipocine Inc ORAL COMPOSITIONS CONTAINING 17- HYDROXYPROGESTERONE ESTER AND RELATED METHODS
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (en) 1976-11-30 1979-06-08 Besins Jean Louis NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
CA2169840A1 (en) 1995-03-02
DK95093D0 (en) 1993-08-20
NO960653L (en) 1996-02-19
AU7530594A (en) 1995-03-21
KR960703570A (en) 1996-08-31
LT4043B (en) 1996-09-25
PL313113A1 (en) 1996-06-10
EP0789560A1 (en) 1997-08-20
SK19396A3 (en) 1997-03-05
HUT74167A (en) 1996-11-28
FI960749A0 (en) 1996-02-19
BR9407306A (en) 1996-10-08
NZ271617A (en) 1996-11-26
FI960749A (en) 1996-02-19
WO1995005807A1 (en) 1995-03-02
NO960653D0 (en) 1996-02-19
JPH09501682A (en) 1997-02-18
LT96010A (en) 1996-06-25
CZ42596A3 (en) 1996-06-12
CN1132478A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
HU9600376D0 (en) A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient
ZA941002B (en) Pharmaceutical compositions in semisold form and a device for administration thereof
ZA942804B (en) Oral drug delivery compositions and methods
AU6633394A (en) A device for local drug delivery and methods for using the same
IL101795A0 (en) Pharmaceutical tablet formulations
AU5314490A (en) Sustained release pharmaceutical preparations containing an analgesic and a decongestant
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
AU2885892A (en) Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate
EP0591421A4 (en) Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
EP0582169A3 (en) Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
IL106578A0 (en) A method and pharmaceutical compositions for drug targeting
EP0542299A3 (en) Ester linkage containing polymers for use in pharmaceutical preparations
HUT71131A (en) Paramycin formulations for oral administration
IL106887A (en) Pharmaceutical and diagnostic compositions and a method for drug targeting
GB9319371D0 (en) Medication administration apparatus
AU627811B2 (en) Apparatus and techniques for administering veterinary medicaments
AU8614291A (en) Device for administering drugs
GB9311030D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
IL108031A0 (en) Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
NZ234803A (en) Oxazolopyridine derivatives and analgesic pharmaceutical compositions
ZA951789B (en) Pharmaceutical materials and methods of administration
GB9215980D0 (en) Pharmaceutical spheroid formulation
ZA9710923B (en) Pharmaceutical compositions and a device for their administration
ZA906792B (en) Pharmaceutical compositions and a device for administering the same

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee